v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 2,411 $ 2,072
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion (including amortization of nuclear fuel) 3,659 3,100
Equity component of AFUDC (147) (116)
Losses on sales of Commercial Renewables Disposal Groups 4 5
Gains on sales of other assets (20) (18)
Impairment of assets and other charges 3 44
Deferred income taxes 611 264
Equity in earnings of unconsolidated affiliates (22) (38)
Payments for asset retirement obligations (241) (262)
(Increase) decrease in    
Net realized and unrealized mark-to-market and hedging transactions 266 (37)
Receivables 53 (19)
Inventory 85 (86)
Other current assets (243) 502
Increase (decrease) in    
Accounts payable (987) (215)
Taxes accrued (7) (68)
Other current liabilities (374) (257)
Other assets (82) 331
Other liabilities 71 225
Net cash provided by operating activities 5,040 5,427
CASH FLOWS FROM INVESTING ACTIVITIES    
Capital expenditures (6,428) (6,204)
Contributions to equity method investments 0 (8)
Purchases of debt and equity securities (3,446) (2,275)
Proceeds from sales and maturities of debt and equity securities 3,535 2,319
Net proceeds from the sales of Commercial Renewables Disposal Groups 559 0
Other (484) (407)
Net cash used in investing activities (6,264) (6,575)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the issuance of long-term debt 4,848 6,372
Issuance of common stock 14 20
Payments for the redemption of long-term debt (1,815) (2,731)
Proceeds from the issuance of short-term debt with original maturities greater than 90 days 0 502
Payments for the redemption of short-term debt with original maturities greater than 90 days (5) (824)
Notes payable and commercial paper (185) (414)
Contributions from noncontrolling interests 0 47
Dividends paid (1,610) (1,590)
Other (2) (108)
Net cash provided by financing activities 1,245 1,274
Net increase in cash, cash equivalents and restricted cash 21 126
Cash, cash equivalents and restricted cash at beginning of period 421 357
Cash, cash equivalents and restricted cash at end of period 442 483
Significant non-cash transactions:    
Accrued capital expenditures $ 1,929 $ 1,721